Community-based ways to boost RSV vaccine use in Latino adults
This study looks at community-based ways to help Latino adults ages 50 and older in San Francisco and Daly City get the RSV vaccine. The goal is to learn what works best to increase vaccination rates.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years or older
- You identify as Latino, Latina, Latinx, or as part of an indigenous group from Latin America
- You have not yet received the RSV vaccine
- You live or work in San Francisco or Daly City and plan to stay for the next year
- You speak English or Spanish and have a cell phone
- You are not living in a nursing home and no one in your household is already in this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses smartphone technology to help new parents get RSV protection for their babies. RSV is a common virus that can cause serious breathing problems in infants, and this trial tests whether AI-assisted reminders can improve prevention rates.
This study tests whether connecting with friends and health workers can help more Latino people in Maryland get vaccinated or boosted against COVID-19. It aims to reach both those who are already vaccinated and those who are hesitant.
This trial tests an experimental vaccine to protect older adults against respiratory syncytial virus (RSV), a common virus that can cause serious lung infections. It looks at whether the vaccine is safe and how well it boosts immunity. If you are healthy and over 60, you might be able to join.
This trial tests a program to help community health centers recommend and boost HPV vaccination rates among Latino adolescents aged 11-12. It aims to support health care providers and staff with education and resources.
This study looks at how to increase preventive care—especially flu and pneumonia vaccines—in people age 70 and older. It may help you get up to date on vaccines that can lower the risk of serious infections.
This study tests an RSV vaccine in adults aged 18 and older, especially those with chronic health issues like heart or lung disease. It aims to see how safe and effective the vaccine is at preventing RSV infections.
Hear when a new Social Networks trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.